The Hematologist
The Hematologist is the member newsletter of the American Society of Hematology (ASH), designed for its broad constituency working to conquer blood diseases. It updates readers on important developments in hematology and highlights ASH's activities for its members.
Episodes
One on One With Mary Horowitz
In this episode contributing editor, Lori Muffly, MD, MS, speaks with a celebrated leader in the field of bone marrow transplantation, Mary Horowitz, MD, MS, of the Medical College of Wisconsin.
A Secondary Consideration: How Real-World Evidence Can Inform Practice in the Management of Patients With Secondary CNS Lymphoma
In this episode, Contributing Editor, Brian Hill, MD, speaks with Juan Alderuccio, MD, of the University of Miami Cancer Center, about a landmark study that supports refined treatment approaches for secondary central nervous system large B-cell lymphoma.
Targeting the Lectin Pathway in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy
In this episode, Contributing Editor Meera Sridharan, MD, PhD, speaks with Hiroyuki Matsui, MD, PhD, assistant professor in the department of hematology at Kyoto University Hospital in Japan. Their conversation focuses on the role of narsoplimab in treating a potentially fatal hematologic disorder.
Search for the Fountain of Youth: Can Bispecific Antibodies Resurrect Dysfunctional T Cells to Improve Outcomes in Richter Transformation?
In this episode, Contributing Editor Tycel Phillips, MD, speaks with Arnon Kater, MD, of Amsterdam University Medical Center in the Netherlands. Their conversation focuses on the potential role of bispecific antibodies in managing patients with Richter transformation.
Not All Clots Are Created Equal: Refining Secondary Prevention of Venous Thromboembolism in Higher-Risk Patients
In this episode, Michael Scott, MD, from the University of Toronto, St. Michael’s Hospital, speaks with Samuel Wilson, MD, of the University of North Carolina at Chapel Hill. Their conversation focuses on recent trials examining secondary prevention of venous thromboembolism in higher-risk patients.
Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia
In this episode, Contributing Editor Brian Hill, MD, PhD, speaks with Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center in New York. Their conversation focuses on Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia.
VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia
In this episode, Contributing Editor Charlotte Brierley, MD, PhD, speaks with Jacqueline Garcia, MD, assistant professor at the Dana Farber Cancer Institute and Harvard Medical School and an expert in myeloid neoplasms. Their discussion focuses on the VERONA trial and its impact on the myelodysplastic syndromes community.
Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society
In this episode Contributing Editor Brian Hill, MD, talks with Brian Koffman, MDCM, retired family doctor and chronic lymphocytic leukemia patient. Dr. Koffman is co-founder and chief medical officer of the CLL Society. They discuss Dr. Koffman’s journey as both a physician and a patient.
An Homage to the Treg Graft in Allogeneic Transplantation
In this episode, Shaji Kumar, MD, editor-in-chief of The Hematologist, and consultant in hematology at Mayo Clinic in Rochester, Minnesota, talks with Robert Negrin, MD, professor of medicine at Stanford University and president-elect of ASH. They discuss recent developments in reducing graft versus host disease in allogenic stem cell transplant.
Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients
In this episode, Contributing Editor Samuel Wilson, MD, talks with Francis Couturaud, MD, PhD, Professor of Pulmonology at University of Brest in France. They discuss low-dose direct oral anticoagulants for extended venous thromboembolism prophylaxis.
GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias
In this episode, Contributing Editor, Lauren Pommert, MD, MS, leads a conversation with Karen Rabin, MD, PhD, pediatric oncologist at the University of California, San Francisco, and Hans Hitzler, MD, with SickKids Children's Hospital in Toronto. They discuss advances in understanding the disease biology of down syndrome associated acute leukemia. Support for this episode provided by Auto
More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia
In this episode, Contributing Editor Lori Muffly, MD, MS, leads a conversation with two patients — Matt and Rohan — both of whom have undergone cord blood transplants for their acute myeloid leukemia. They discuss the value of peer connection as a vital component of their leukemia and transplant journey.
Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia
In this episode, Contributing Editor Surbhi Shah, MBBS, MD, a clinician, researcher, and educator at Mayo Clinic in Phoenix, Arizona, talks with Keith McCrae, MD, director of classical hematology at the Taussig Cancer Institute and professor of molecular medicine at the Cleveland Clinic Lerner College of Medicine in Ohio. They discuss a recent paper co-authored by Dr. McCrae, “Pomalidomid
Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
In this episode, Contributing Editor Scott Furlan, MD, PhD, an assistant professor at the Fred Hutch Cancer Center and Department of Pediatrics at the University of Washington in Seattle, talks with Daniel J. DeAngelo, MD, PhD, chief of the leukemia division at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School in Boston. They discuss a phase I study wi
When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists
In this episode, Contributing Editor Michael Scott, MD, a hematologist at St. Michael’s Hospital in Toronto, Canada, and an assistant professor at the University of Toronto, talks with Marc Michel, MD, MSc, head of the internal medicine and clinical immunology department at Henri Mondor University Hospital in Créteil, France. They talk about long-term follow-up of the STOPAGO study, which
No Scientific Link Found Between Sickle Cell Trait and Sudden Death
In this episode, Contributing Editor Samuel Wilson, MD, MSCR, an assistant professor of hematology at the University of North Carolina at Chapel Hill, talks with Michael DeBaun, MD, MPH, a professor of pediatrics and medicine at Vanderbilt University Medical Center and founder and director of the Vanderbilt-Meharry Sickle Cell Disease Center of Excellence. They talk about a systematic lit
Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin
In this episode, Contributing Editor Tycel Phillips, MD, an associate professor of medicine and a hematologist-oncologist at City of Hope Medical Center in Duarte, California, talks with Jeremy Abramson, MD, director of the Jon and Jo Ann Hagler Center for Lymphoma at Massachusetts General Hospital and an associate professor of medicine at Harvard Medical School. They talk about the use o
The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.
In this episode, Contributing Editor Lori Muffly, MD, MS, an associate professor of medicine at Stanford University where she focuses on cellular therapy for adults with acute leukemia, talks with Steven Devine, MD, the chief medical officer at the National Marrow Donor Program. They talk about the rise of HLA-mismatched unrelated donor transplants in the U.S.
The End of Transplant for Mantle Cell Lymphoma
In this episode, Contributing Editor Brian Hill, MD, PhD, director of the lymphoid malignancies program at the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, talks with Tim Fenske, MD, who at the time of this recording was joining the transplant and cell therapy group at Sarah Cannon Methodist Healthcare in San Antonio, Texas. Dr. Fenske previously led the lymphoma program
DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma
In this episode, Contributing Editor Ajai Chari, MD, a professor of clinical medicine and director of the myeloma program at the University of California San Francisco, talks with Meletios Dimopoulos, MD, a professor and chair of the Department of Clinical Therapeutics at the National and Kopodistrian University of Athens School of Medicine in Athens, Greece. They talk about a recent pape
Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease
In this episode, Contributing Editor Samuel Wilson, MD, an assistant professor of hematology at the University of North Carolina Chapel Hill, talks with Adetola Kassim, MD, a professor of medicine in the division of hematology and oncology at Vanderbilt University Medical Center. They talk about a recent paper co-authored by Dr. Kassim: “An International Learning Collaborative Phase 2 Tri
Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?
In this episode, Contributing Editor Lauren Pommert, MD, a pediatric oncologist specializing in children with leukemia at Cincinnati Children's in Cincinnati, Ohio, talks with Natalie DelRocco, PhD, a senior statistician for the Children’s Oncology Group’s Bone Tumors Committee and an assistant professor of clinical population and public health sciences in the Division of Biostatistics at
A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission
In this episode, Contributing Editor Tycel Phillips, MD, an associate professor of medicine and a hematologist-oncologist at City of Hope Medical Center in Duarte, California, talks with Martin Dreyling, MD, a professor of medicine and head of the lymphoma program at LMU Hospital in Munich. They discuss the TRIANGLE trial, conducted by Dr. Dreyling and colleagues, for the European Mantle
Anticoagulation Stewardship
In this episode, Contributing Editor Surbhi Shah, MD, a classical hematologist at Mayo Clinic in Phoenix, leads a conversation about anticoagulation stewardship. Her guests are Allison Burnett, PharmD, PhC, an antithrombosis stewardship pharmacist at the University of New Mexico Hospital and president of the Anticoagulation Forum, and Geoffrey Barnes, MD, MSc, an associate professor and v
Blood Global Hematology Editor-in-Chief Shares Vision
In this episode, Editor-in-Chief Shaji Kumar, MD, a professor of medicine at Mayo Clinic in Rochester, Minnesota, talks with Jorge Cortes, MD, the inaugural editor-in-chief of Blood Global Hematology, one of the latest additions to the growing Blood journals portfolio. Dr. Cortes, director of the Georgia Cancer Center at Augusta University, shares his vision for the journal and his thoug
One on One With Dr. Fred Appelbaum
In this episode, Contributing Editor Lori Muffly, MD, MS, an associate professor of medicine specializing in blood and marrow transplantation and cellular therapy at Stanford University in California, talks with Fred Appelbaum, MD, executive vice president and deputy director at the Fred Hutchinson Cancer Center in Seattle, and a professor of medicine in the division of hematology and onc
Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms
In this episode, Contributing Editor Bethan Psaila, MD, PhD, an associate professor of hematology at the University of Oxford’s MRC Weatherall Institute of Molecular Medicine, talks with Andrew Dunbar, MD, an assistant professor and independent lab investigator at MD Anderson Cancer Center in Houston, Texas. They discuss Dr. Dunbar’s paper recently published in Cancer Discovery: “JAK2V617
Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives
In this episode, Contributing Editor Samuel Wilson, MD, an assistant professor of hematology at the University of North Carolina, Chapel Hill, talks with Marc Blondon, MD, an attending physician in the division of angiology and hemostasis with the University Hospitals of Geneva (Switzerland). They talk about a paper co-authored by Dr. Blondon titled, “Longitudinal profile of estrogen-rela
Growing the Next Generation of Hematologists
In this episode, Editor-in-Chief Shaji Kumar, MD, a professor of medicine at Mayo Clinic in Rochester, Minnesota, talks with Leslie Ellis, MD, a professor of internal medicine at Atrium Health Wake Forest Baptist in Winston Salem, North Carolina. They discuss the ASH Ambassador Program, which is designed to support the recruitment and retention of trainees into hematology. Dr. Ellis is ch
Women in Hematology
In this episode, Tamara Dunn, MD, a clinical associate professor of medicine in the division of hematology at Stanford University in Stanford, California, and co-chair of ASH’s Women in Hematology Working Group, hosts a conversation with Toyosi Onwuemene, MD, an associate professor of medicine, specializing in hemostasis/thrombosis, at Duke University in Durham, North Carolina, and Nina S
Four Is Better Than Three: Will We Finally Agree?
In this episode, Contributing Editor Ajai Chari, MD, a professor of clinical medicine and director of the myeloma program at the University of California San Francisco, talks with Pieter Sonneveld, MD, PhD, a professor of hematology at the Erasmus University of Rotterdam in the Netherlands. They discuss Dr. Sonneveld’s recent paper, “Daratumumab, Bortezomib, Lenalidomide, and Dexamethason
Toward Equity in Access for ALL
In this episode, Contributing Editor Lori Muffly, MD, an associate professor of medicine specializing in blood and marrow transplantation and cellular therapies at Stanford University in California, talks with Roberta Demichelis, MD, an assistant professor in the department of hematology and oncology at the Salvador Zubirán National Institute of Health Sciences and Nutrición in Mexico Cit
The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia
In this episode, Contributing Editor Sarah Tasian, MD, associate professor at the University of Pennsylvania School of Medicine and chief of the hematologic malignancies program at the Children’s Hospital of Philadelphia, talks with Rob Pieters, MD, the chief medical officer at the Princess Maxima Center for Pediatric Oncology and professor of pediatric oncology at the University of Utrec
Editors-in-Chief of Two New ASH Journals Share Their Visions
In this episode, Dr. Shaji Kumar, editor-in-chief of The Hematologist, has a conversation with Drs. Jonathan Licht and Keith McCrae, the editors-in-chief, respectively, of ASH's two new journals Blood Neoplasia and Blood Vessels, Thrombosis & Hemostasis.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/
ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All
In this episode, Dr. Satiro De Oliveira talks about his own experience with the mentorship program within ASH’s Minority Recruitment Initiative and its impact on trainees coming from underrepresented groups. Dr. De Oliveira is an associate professor in the Division of Pediatric Hematology Oncology at UCLA.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative
Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?
In this episode, Contributing Editor Kate Markey, MBBS, PhD, talks with Shernan Holtan, MD, one of the authors of a paper published recently in The New England Journal of Medicine: “Post-transplantation Cyclophosphamide-based Graft-versus-host Disease Prophylaxis.”Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommo
Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal
In this episode, Contributing Editor Dr. Robert Hasserjian has a conversation with Dr. Siddhartha Jaiswal about a recent paper Dr. Jaiswal co-authored: “Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.” Dr. Hasserjian is a professor of pathology at Harvard Medical School. He is also the director of the Hematopathology Fellowship Program at Massachusetts
Drawing New Blood Into Hematology
In this episode, Drs. Robert Stern and Ronak Mistry talk about their own professional journeys as hematologists, why they love what they do, the medical education for hematologists, and recruitment efforts to bring more students into the field.Dr. Stern is the associate program director with the Dana-Farber Massachusetts General Brigham Fellowship in Hematology and Oncology in Boston. Dr.
Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action
In this episode, Contributing Editor Dr. Michael Scott is joined by Dr. Sumedha Arya for a conversation with Dr. Cindy de Jong. They discuss a study covered by Drs. Scott and Arya in their recent Diffusion article titled “Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action.” Dr. de Jong performed analysis for the study and served as one of the lead authors of the
ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology
In this installment, Dr. Nicole Gormley and Dr. Grzegorz Nowakowski discuss a collaboration between ASH and the FDA that led to a successful workshop on regulatory science in hematology, an event they co-chaired and one that will return Oct. 10–11 at ASH headquarters in Washington, D.C. Dr. Gormley, a hematologist with the FDA, is the Division Director for the Division of Hematologic Mali
The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma, with Drs. Michael Dickinson and Loretta J. Nastoupil
In this installment, Contributing Editor Dr. Loretta J. Nastoupil has a conversation with Dr. Michael Dickinson. They discuss the New England Journal of Medicine article covered by Dr. Nastoupil in her most recent Diffusion article titled, “The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma.” In the article, Dr. Nastoupil discusses a study that looks at
VTE Guidelines for Latin America Special Populations and Diagnosis (Portuguese Audio)
Nesta segunda parte de nossa serie sobre a adaptação das Diretrizes de Prática Clínica da ASH sobre tromboembolismo venoso na América Latina, Dra. Suely Meireles Rezende e Dr. Daniel Días Ribeiro discutem a publicação das diretrizes para prevenção de tromboemboilsmo venoso em pacientes na América Latina. Este podcast é a versão em português de uma série especial com episódios em inglês, e
VTE Guidelines for Latin America Special Populations and Diagnosis (Spanish Audio)
En este episodio de nuestra serie sobre las Guías de Práctica Clínica de ASH, la Dra. Pamela Zuñiga y el Dr. Pedro Pablo García Lázaro Guillermo conversan sobre la importancia clínica de las nuevas Guías de ASH para el Manejo del Tromboembolismo Venoso para América Latina. Este podcast es la versión en español de una serie especial de tres partes con episodios en inglés, español, y portug
VTE Guidelines for Latin America Special Populations and Diagnosis (English Audio)
In this installment of our ASH Clinical Practice Guidelines series, Dr. Luis Meillon and Dr. Jaime Pereira have a conversation about the clinical importance of new ASH Guidelines on Venous Thromboembolism in Latin America. This podcast is the English version of a dedicated three-part series in English, Spanish, and Portuguese. Dr. Luis Meillon is a hematologist at the ABC Medical Center a
ASH Summit on Immunotherapies for Hematologic Diseases, With Dr. Terry Fry and Dr. Shaji Kumar
In this installment, 2023 ASH Summit on Immunotherapies for Hematologic Diseases co-chair Dr. Terry Fry, and The Hematologist Editor-in-Chief Dr. Shaji Kumar have a conversation about what attendees can expect for this year’s summit, taking place in-person only. They discuss the current progress of immunotherapies for treating hematologic malignancies, some of the limitations to bringing
GPRC5D: The Next Frontier for Immunotherapy in Multiple Myeloma, With Drs. Shaji Kumar and Saad Usmani
In this installment, The Hematologist Editor-in-Chief Dr. Shaji Kumar has a conversation with Contributing Editor Dr. Saad Usmani. They discuss Dr. Usmani’s Year’s Best coverage in which he describes the past year’s breakthroughs in immunotherapies for multiple myeloma. The focus in particular on B-cell maturation antigen (BCMA) –targeted therapies, including chimeric antigen receptor T-c
Should Minimal Residual Disease Guide the Way? With Drs. Partow Kebriaei and Lori Muffly
In this installment, Contributing Editor Dr. Lori Muffly has a conversation with Dr. Partow Kebriaei. They discuss the Blood article covered by Dr. Muffly in her most recent Diffusion article titled, “Should Minimal Residual Disease Guide the Way? The Evolving Role of Allogeneic Hematopoietic Cell Transplantation for Adults With Ph+ Acute Lymphoblastic Leukemia in First Complete Remission
ASH Celebrates Hispanic Heritage Month, With Drs. Ruben Mesa, Diego Adrianzen-Herrera, & Joanna Robles, Introduced by Dr. Belinda Avalos
In this installment, Dr. Ruben Mesa leads a conversation in honor of Hispanic Heritage Month, in an interview with Dr. Diego Adrianzen-Herrera and Dr. Joanna Robles. They share their experiences as hematologists of Hispanic/LatinX heritage and discuss the role of mentorship and ASH in their work, what led them to their careers in medicine, and what they as individuals can do to ensure the
ASH Celebra el Mes de la Herencia Hispana, Con el Dr. Ruben Mesa, el Dr. Diego Adrianzen-Herrera, & la Dra. Joanna Robles
En este episodio, el Dr. Rubén Mesa entrevista al Dr. Diego Adrianzen-Herrera y la Dra. Joanna Robles en honor del Mes de la Herencia Hispana sobre sus experiencias como hematólogos de ascendencia hispana/latina, la importancia de ASH y un buen mentor en sus carreras, lo que los llevó a estudiar medicina, y la forma de garantizar que la comunidad hispana tenga una voz en el sector de la h
Iron-restricted Erythropoiesis in Sickle Cell Disease, With Drs. David Rees, Naja Nyffenegger, & Vania Manolova
In this installment, Contributing Editor Dr. David Rees has a conversation with Drs. Naja Nyffenegger and Vania Manolova. They discuss the Blood article covered by Dr. Rees in his most recent Diffusion article titled, “Iron-restricted Erythropoiesis in Sickle Cell Disease.” In the article, Dr. Rees explored the study by Dr. Nyffenegger and colleagues, which hypothesized that iron restrict
ASH and Maternal Health, With Drs. Jennifer Holter-Chakrabarty & Sarah O’Brien
In this episode, Dr. Jennifer Holter-Chakrabarty, chair of the ASH Committee on Government Affairs, and Dr. Sarah O’Brien, chair of the ASH Working Group on Maternal Health in Hematology have a conversation about recent issues facing maternal health care, and what the Society and its membership is doing to confront these challenges, through advocacy and education. Music: “Jellyfish in Spa
Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy, With Drs. Loretta Nastoupil & Melody Smith
In this installment, Contributing Editor Dr. Loretta Nastoupil has a conversation with Dr. Melody Smith. They discuss a Nature Medicine article covered by Dr. Nastoupil in her most recent Diffusion article titled, “Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy.” In the article, Dr. Nastoupil discusses a study that explored whether an
The Latest Sickle Cell Disease Policy Updates, With Drs. Jennifer Holter Chakrabarty & Chancellor Donald
In this installment, ASH Committee on Practice Chair Dr. Chancellor Donald and ASH Committee on Government Affairs Chair Dr. Jennifer Holter Chakrabarty provide an overview of the latest sickle cell disease (SCD) policy updates and highlight ASH's work to date on the Hill, including a recently introduced SCD bill, and work with the U.S. Department of Health and Human Services and other fe
Structural Racism and Understanding Disparities in AML Outcomes, With Drs. Christine McMahon & Ivy Abraham
In this installment, Contributing Editor Dr. Christine McMahon has a conversation with Dr. Ivy Abraham. They discuss a Blood article covered by Dr. McMahon in her most recent Diffusion article titled, “Toward Understanding Disparities in AML Outcomes: The Role of Structural Racism.” In the article, Dr. McMahon discusses an analysis of data showing disparities in acute myeloid leukemia (AM
A Conversation About Women in Medicine, With Drs. Shikha Jain and Laura Michaelis
In this installment, Editor-in-Chief Dr. Laura Michaelis interviews Dr. Shikha Jain. In this interview, Dr. Michaelis and Dr. Jain chat about female physicians' experience in the workforce, women in medicine, and discuss a series of articles and studies on why they are leaving the workforce and how their experiences compare to their male counterparts. Visit the ASH website to learn about
ASH VTE-LA Guidelines: Prevention of VTE in Latin America, With Drs. Patricia Casais & Luis Meillon-Garcia
English Version: In this podcast, 2022 ASH Guidelines for Prevention of Venous Thromboembolism in Latin American panel members Dr. Patricia Casais and Dr. Luis Meillon-Garcia have a conversation about the clinical importance of new Guidelines on Venous Thromboembolism in Latin America in medical and surgical patients and long-distance travelers in Latin America. Learn more by visiting www
Modelling Myelofibrosis in Vivo: Success With NSG-S, With Drs. Beth Psaila and Hamza Celik
In this podcast, Contributing Editor Dr. Beth Psaila has a conversation with Dr. Hamza Celik. They discuss a Cancer Discovery article covered by Dr. Psaila in her most recent Diffusion article titled, “Modeling Myelofibrosis in Vivo: Success With NSG-S.” In the article, Dr. Psaila discusses an optimized approach for engrafting myelofibrosis CD34+ stem/progenitor cells from peripheral bloo
Guías TEV-LA: Prevención de TEV en América Latina, Con Dras. Cecilia Colorio y Cecilia Guillermo
Spanish Version/Versión en Español: En este pódcast, miembros del Panel LATAM ASH TEV, Dra. Cecilia Colorio y Dra. Cecilia Guillermo, conversan sobre la importancia clínica de las nuevas Guías Para la Prevención del Tromboembolismo Venoso para América Latina, en pacientes quirúrgicos, médicos, y viajeros de larga distancia. Visite www.hematology.org/vte para mٔás información y lea las guí
Diretrizes TEV-LA: Prevenção de TEV na América Latina, Com Dr. Suely Rezende e Daniel Ribeiro
Portuguese Version/Versão em Português: Neste podcast, Doutora Suely Rezende e Doutor Daniel Ribeiro, membros do Painel LATAM ASH TEV, conversam sobre a importância clínica das novas Diretrizes Para a Prevenção do Tromboembolismo Venoso em pacientes cirúrgicos e hospitalizados, e viajantes de longa distância na América Latina. Visite www.hematology.org/vte para mais informações e leia as
An Interview With Pediatric Physician Scientist, Advocate, and Mentor Dr. Rayne Rouce
In this installment, Editor-in-Chief Dr. Laura Michaelis interviews Dr. Rayne Rouce. Amazing doctors are leading the way for a future generation of hematologists through their inspiring work and intentional commitment to make a positive change in the medical field. In this interview, Dr. Michaelis and Dr. Rouce chat about Dr. Rouce’s work with children as a pediatric hematologist/oncologi
From Myth to Reality: Achieving Second Remission in ALL, With Drs. Kristen O'Dwyer & Laura Michaelis
In this podcast, Editor-in-Chief Dr. Laura Michaelis has a conversation with Contributing Editor Dr. Kristen O'Dwyer. They discuss Dr. O'Dwyer's pick for the best of 2021 on achieving a second remission in patients with acute lymphoblastic leukemia (ALL). You can access her Year's Best article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.1.2022110/4833
2021 ASH Annual Meeting: Plenary Abstract on ZUMA-7 Study, With Drs. Frederick Locke & Brad Kahl
In this installment of our 2021 ASH Annual Meeting Podcast series, Contributing Editor Dr. Brad Kahl has a conversation with Contributing Editor Dr. Frederick Locke about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract presents an analysis of the ZUMA-7 trial of axicabtagene ciloleucel versus standard-of-care therapy in patients
2021 ASH Annual Meeting: COVID-19 Content at the Meeting, With Drs. Cindy Dunbar and Laura Michaelis
In this installment of our 2021 ASH Annual Meeting Podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with ASH Secretary Dr. Cindy Dunbar about the COVID-19–related content that will be presented at the 2021 ASH Annual Meeting. For coverage of abstracts, sessions, and other events, check www.ashpublications.org/ashnewsdaily throughout the meeting. Visit www.hematology.
2021 ASH Annual Meeting: Plenary Abstract on ATLAS-INH in Patients With Hemophilia A or B With Inhibitors, Drs. Guy Young & Laura Michaelis
In this installment of our 2021 ASH Annual Meeting Podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Guy Young about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract evaluates the efficacy and safety of fitusiran prophylaxis in a multicenter phase 3 study (ATLAS-INH) in patients with hemophilia A or
Weighing the Risks and Benefits of DOACs in Morbidly Obese Patients, With Drs. Damon Houghton & Karlyn Martin
In this podcast, Contributing Editor Dr. Damon Houghton has a conversation with Dr. Karlyn Martin. They discuss a Journal of Thrombosis and Haemostasis article covered by Dr. Houghton in his most recent Diffusion article titled, “Weighing the Risk and Benefits of Direct Oral Anticoagulants in Morbidly Obese Patients: New Data and Guidance.” In the article, Dr. Houghton discusses the updat
ASH VTE Guidelines & COVID-19 Update: Use of Anticoagulation in Patients With COVID-19, With Drs. Laura Michaelis, Adam Cuker & Reem Mustafa
In this installment of our ASH Clinical Practice Guidelines and our COVID-19 series, Editor-in-Chief Dr. Laura Michaelis has a conversation with the Use of Anticoagulation in Patients with COVID-19 guideline panel co-chairs Dr. Adam Cuker and Dr. Reem Mustafa. They discuss the clinical importance of these guidelines as well as the process to track and respond to the ongoing emergence of n
Genome Editing: Fetal Origins of AML in Down Syndrome, With Drs. Adam Mead & Elvin Wagenblast
In this podcast, Contributing Editor Dr. Adam Mead has a conversation with Dr. Elvin Wagenblast. They discuss Dr. Mead’s Diffusion article from the September/October 2021 issue of The Hematologist, titled, "Genome Editing: The Fetal Origins of Acute Myeloid Leukemia in Down Syndrome." They discuss a study that used CRISPR/Cas9 genome editing of hematopoietic stem and progenitor cells from
Diretrizes TEV-LA: Gestão de TEV na América Latina, Com Dr. Suely Rezende e Daniel Ribeiro
Neste podcast, Doutora Suely Rezende e Doutor Daniel Ribeiro, membros do Painel LATAM ASH TEV, conversam sobre a importância clínica das novas Diretrizes Para o Tratamento do Tromboembolismo Venoso na América Latina. Visite www.hematology.org/vte para mais informações e leia as diretrizes completas na publicação da Blood Advances: https://ashpublications.org/bloodadvances/article/5/15/303
Guías TEV-LA: Manejo de TEV en América Latina, Con Dras. Cecilia Colorio y Cecilia Guillermo
Spanish Version/Versión Español:
En este pódcast, miembros del panel Panel LATAM ASH TEV, Dra. Cecilia Colorio y Dra. Cecilia Guillermo, conversan sobre la importancia clínica de las nuevas Guías Para el Manejo del Tromboembolismo Venoso para América Latina. Visite www.hematology.org/vte para mٔás información y lea las guías completas en una publicación de Blood Advances: https://ashpubl
ASH VTE-LA Guidelines: Management of VTE in Latin America, Drs. Patricia Casais & Guillermo León
English Version: In this podcast, 2021 ASH Guidelines for Management of Venous Thromboembolism in Latin American panel members Dr. Patricia Casais and Dr. Guillermo León Basantes have a conversation about the clinical importance of new Guidelines on Venous Thromboembolism in Latin America. Learn more by visiting www.hematology.org/vte, and read the full guideline in a Blood Advances publi
Coming Soon: 3-Part Podcast Series on ASH VTE Guidelines in Latin America
Coming Soon: In an upcoming installment of our ASH Clinical Practice Guidelines series, panel members from the 2021 Guidelines for the Management of Venous Thromboembolism in Latin America will discuss the clinical importance of the new guidelines on VTE in Latin America. Join us each week for new episodes in English, Spanish, and Portuguese featuring panel members discussing the contextu
The ASH Journal Club, With Drs. Olga Guryanova and Andrew Volk
In this installment of The Hematologist podcast, members of the ASH Taskforce on PhD Careers in Hematology Dr. Olga Guryanova and Dr. Andrew Volk have a conversation about the ASH Journal Club, a new series that will highlight seminal papers in hematology published in Blood and Blood Advances, featuring a manuscript author and moderated discussion. Learn more by visiting https://www.hemat
Immune Therapies for Myeloma, With Drs. Saad Usmani and Nikhil Munshi
In this podcast, Contributing Editor Dr. Saad Usmani has a conversation with Dr. Nikhil Munshi. They discuss Dr. Usmani’s Mini Review article from the July/August 2021 issue of The Hematologist, titled, "Immune Therapies for Myeloma: The CARs Are Here but What’s Next?" They discuss the latest approvals of chimeric antigen receptor T-cell therapies to treat multiple myeloma. You can access
Chemotherapy Drug Shortages in Pediatric Oncology, With Drs. Sarah Tasian and Yoram Unguru
In this podcast, Contributing Editor Dr. Sarah Tasian has a conversation with Dr. Yoram Unguru. They discuss Dr. Tasian’s Feature article from the July/August 2021 issue of The Hematologist, titled, "Chemotherapy Drug Shortages in Pediatric Oncology: A Global Public Health Crisis Threatening Our Children." They shed light on chemotherapy drug shortages currently affecting pediatric cancer
COVID-19 Update 19: Infection in CLL Patients & Vaccine Response, Drs. Cindy Dunbar & John Gribben
In this installment of our special COVID-19 podcast series, ASH Secretary Dr. Cindy Dunbar has a conversation with Dr. John Gribben. They discuss COVID-19 infection in patients with chronic lymphocytic leukemia or indolent lymphoma, including outcomes of infection, impact of CLL status and of treatment, changes to treatment approaches in the context of the pandemic, and the issues surroun
The ASH Hematology Review Series, With Drs. Leidy Isenalumhe and Lachelle Dawn Weeks
In this installment of The Hematologist podcast, Chair of the ASH Hematology Review Series Task Force Dr. Leidy Isenalumhe and Chair of the ASH Trainee Council Dr. Lachelle Dawn Weeks have a conversation about the ASH Hematology Review Series, a free series designed for fellows preparing to take the internal medicine hematology certification examination or those desiring a comprehensive u
Nutrient Deficiencies Linked to Worse Outcomes in SCD, Drs. Laura Michaelis & Ify Osunkwo
In this podcast, Editor-in-Chief Dr. Laura Michaelis has a conversation with Contributing Editor Dr. Ifeyinwa (Ify) Osunkwo. They discuss Dr. Osunkwo’s Diffusion article from the May/June 2021 issue of The Hematologist, titled, "You Are What You Don’t Eat: Micro- and Macronutrient Deficiencies Linked to Worse Outcomes in Sickle Cell Disease." They talk about the influence of nutrition on
ASH ICAL Next-generation Sequencing Program, Drs. Peter Valk, Torsten Haferlach & Pamela Mora
In this installment of The Hematologist podcast, Dr. Peter Valk and Dr. Torsten Haferlach have a conversation about ASH International Consortium on Acute Leukemia’s Next-generation Sequencing program. We will also hear from Dr. Pamela Mora about her experience as a lab tech under the mentorship of Dr. Valk. Learn more by visiting https://www.hematology.org/global-initiatives/international
COVID-19 Update 18: ASH RC COVID-19 Registry for Hematology, Drs. Michaelis, Hicks, Wood, & Desai
In this installment of our special COVID-19 podcast series, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Drs. Lisa Hicks, Bill Wood, and Pinkal Desai. They provide the latest updates on the ASH Research Collaborative COVID-19 Registry for Hematology, and we hear from Dr. Pinkal Desai about her experience using the registry and submitting patient data. To ac
COVID-19 Update 17: COVID-19 Vaccines, With Drs. Laura Michaelis, Jeffery Auletta & Adrian Wiestner
In this installment of our special COVID-19 podcast series, The Hematologist Editor-in-Chief Dr. Laura Michaelis has a conversation with Drs. Jeffery Auletta and Adrian Wiestner. They discuss the latest news surrounding the COVID-19 vaccine, including vaccination guidelines and frequently asked questions, as they relate to the hematology community. Find additional ASH resources available
Recommended
پلی لیست | PlayList
Conspiracy Files with Paige Carter
Bad Friends
Learn 50 English Phrases While You Sleep | Everyday English Phrases & Vocabulary
This Past Weekend w/ Theo Von
Dateline NBC
Back to the 80s Radio
Crime Stories with Nancy Grace
Bible Tea
این نقطه
TED Business
Dark Night Tales with Brian King
